1. Home
  2. ANGO vs CGC Comparison

ANGO vs CGC Comparison

Compare ANGO & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AngioDynamics Inc.

ANGO

AngioDynamics Inc.

HOLD

Current Price

$15.30

Market Cap

420.2M

Sector

Health Care

ML Signal

HOLD

Logo Canopy Growth Corporation

CGC

Canopy Growth Corporation

HOLD

Current Price

$0.93

Market Cap

389.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANGO
CGC
Founded
1988
N/A
Country
United States
Canada
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Pharmaceuticals and Biotechnology
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
420.2M
389.2M
IPO Year
2004
2023

Fundamental Metrics

Financial Performance
Metric
ANGO
CGC
Price
$15.30
$0.93
Analyst Decision
Strong Buy
Hold
Analyst Count
5
1
Target Price
$18.00
N/A
AVG Volume (30 Days)
306.1K
2.7M
Earning Date
04-02-2026
05-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
84.17
EPS
N/A
N/A
Revenue
$291,010,000.00
$12,759,000.00
Revenue This Year
$9.51
$8.27
Revenue Next Year
$4.96
$15.68
P/E Ratio
N/A
N/A
Revenue Growth
10.17
N/A
52 Week Low
$9.39
$0.84
52 Week High
$16.29
$2.38

Technical Indicators

Market Signals
Indicator
ANGO
CGC
Relative Strength Index (RSI) 46.50 42.66
Support Level $14.85 $0.91
Resistance Level $16.23 $1.15
Average True Range (ATR) 0.51 0.03
MACD -0.08 -0.01
Stochastic Oscillator 25.00 23.17

Price Performance

Historical Comparison
ANGO
CGC

About ANGO AngioDynamics Inc.

AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.

About CGC Canopy Growth Corporation

Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.

Share on Social Networks: